Pulmonx (LUNG) Shares Outstanding (2019 - 2025)
Pulmonx (LUNG) posted quarterly Shares Outstanding (Entity) of $41.7 million for Q4 2025, up 4.74% year-over-year from $39.8 million in Q4 2024, and up 1.04% quarter-over-quarter from $41.2 million in Q3 2025.
Pulmonx (LUNG) Shares Outstanding (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Shares Outstanding (Entity) for 7 consecutive years, with $41.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 4.74% year-over-year to $41.7 million; the TTM figure through Dec 2025 stood at $41.7 million (up 4.74% YoY), while the FY2025 annual figure was $41.7 million, up 4.74% from the prior year.
- Shares Outstanding (Entity) improved to $41.7 million in Q4 2025 per LUNG's latest filing, from $41.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $41.7 million in Q4 2025 and bottomed at $35.8 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $38.5 million across 5 years, with a median of $38.2 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 1635.08% — and 2022, when it grew 1.6%.
- Pulmonx's Shares Outstanding (Entity) stood at $36.9 million in 2021, then grew by 1.69% to $37.6 million in 2022, then advanced by 2.56% to $38.5 million in 2023, then increased by 3.3% to $39.8 million in 2024, then advanced by 4.74% to $41.7 million in 2025.
- Business Quant data shows LUNG's Shares Outstanding (Entity) at $41.7 million in Q4 2025, $41.2 million in Q3 2025, and $40.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | 40.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.94 Mn |
| Sep 30, 2025 | 40.94 Mn |
| Jun 30, 2025 | 40.43 Mn |
| Mar 31, 2025 | 39.95 Mn |
| Dec 31, 2024 | 39.11 Mn |
| Sep 30, 2024 | 39.28 Mn |
| Jun 30, 2024 | 38.94 Mn |
| Mar 31, 2024 | 38.64 Mn |
| Dec 31, 2023 | 37.97 Mn |
| Sep 30, 2023 | 38.12 Mn |
| Jun 30, 2023 | 37.82 Mn |
| Mar 31, 2023 | 37.57 Mn |
| Dec 31, 2022 | 37.10 Mn |
| Sep 30, 2022 | 37.19 Mn |
| Jun 30, 2022 | 37.00 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Dec 31, 2021 | 36.13 Mn |
| Sep 30, 2021 | 36.45 Mn |
| Jun 30, 2021 | 36.04 Mn |
| Mar 31, 2021 | 35.37 Mn |